Adam Lauring, MD, PhD
Professor of Internal Medicine
Professor of Microbiology and Immunology
Medical School
Professor of Ecology and Evolutionary Biology
College of Literature, Science, and the Arts
[email protected]

Available to mentor
Adam Lauring, MD, PhD
Professor
  • About
  • Links
  • Qualifications
  • Research Overview
  • Recent Publications
    • Manage Your Profile
    About

    Dr. Lauring is a physician-scientist with a research interest in the genetics and evolution of RNA viruses

    Links
    • Lauring Lab
    Qualifications
    • MD
      University of Washington, 2002
    • PhD
      University of Washington, 2000
    • BS
      Yale University, 1994
    Research Overview

    Dr. Lauring’s laboratory has worked in three main areas. First, they study the importance of mutation rate and mutational tolerance to the evolution of poliovirus and influenza virus. More recently, they have utilized next generation sequencing of patient samples to define the within-host evolution and transmission of influenza virus, poliovirus, and SARS-CoV-2. Since the beginning of the COVID pandemic, his laboratory has collaborated with large teams to study the genomic epidemiology of respiratory viruses and the effectiveness of vaccines against them.

    Recent Publications See All Publications
    • Journal Article
      The role of viral interaction in household transmission of symptomatic influenza and respiratory syncytial virus
      Ibiebele JC, Godonou ET, Callear AP, Smith MR, Truscon R, Johnson E, Eisenberg MC, Lauring AS, Monto AS, Cobey S, Martin ET. Nature Communications, 2025 Dec 1; 16 (1): DOI:10.1038/s41467-025-56285-z
      PMID: 39893197
    • Journal Article
      Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States.
      Feldstein LR, Ruffin J, Wiegand RE, Borkowf CB, James-Gist J, Babu TM, Briggs-Hagen M, Chappell J, Chu HY, Englund JA, Kuntz JL, Lauring AS, Lo N, Carone M, Lockwood C, Martin ET, Midgley CM, Monto AS, Naleway AL, Ogilvie T, Saydah S, Schmidt MA, Schmitz JE, Smith N, Sohn I, Starita L, Talbot HK, Weil AA, Grijalva CG. J Infect Dis, 2025 Apr 15; 231 (4): e743 - e753. DOI:10.1093/infdis/jiaf007
      PMID: PMC11998566
    • Journal Article
      Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024.
      Lewis NM, Harker EJ, Cleary S, Zhu Y, Grijalva CG, Chappell JD, Rhoads JP, Baughman A, Casey JD, Blair PW, Jones ID, Johnson CA, Halasa NB, Lauring AS, Martin ET, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Duggal A, Felzer JR, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Ferguson SAN, Mosier J, Qadir N, Chang SY, Ginde AA, Zepeski A, Mallow C, Harris ES, Johnson NJ, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, Surie D, Dawood FS, Ellington S, Self WH. J Infect Dis, 2025 Apr 8; DOI:10.1093/infdis/jiaf185
      PMID: 40198276
    • Journal Article
      Strength and durability of RSV pre-fusion F IgG following infection and exposure in a household cohort, 2014-2022.
      Rumfelt KE, Juntila C, Smith M, Callear A, Yang Y, Monto AS, Lauring AS, Martin ET. J Infect Dis, 2025 Apr 3; DOI:10.1093/infdis/jiaf168
      PMID: 40176487
    • Journal Article
      56 Positive SARS-CoV-2 symptomatology despite persistently negative molecular testing: Insights from a Multicenter Household Transmission Study
      Chan A, Chappell JD, Smith-Jeffcoat SE, Mellis AM, Rolfes MA, Zhu Y, Scott T, Stockwell MS, Maldonado Y, Nguyen H, Lutrick K, Bowman NM, Rao S, Asturias EJ, Ellingson KD, Lauring AS, Talbot HK, Grijalva CG, Schmitz J. Journal of Clinical and Translational Science, 2025 Mar 28; 9 (s1): 17 - 17. DOI:10.1017/cts.2024.735
    • Journal Article
      Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination
      Surie D, Yuengling KA, Safdar B, Ginde AA, Peltan ID, Brown SM, Gaglani M, Ghamande S, Gottlieb RL, Columbus C, Mohr NM, Gibbs KW, Hager DN, O'Rourke M, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Khan A, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Busse LW, Felzer J, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Lauring AS, Martin ET, Mosier JM, Harris ES, Baughman A, Swan SA, Johnson CA, Blair PW, Lewis NM, Ellington S, Rutkowski RE, Zhu Y, Self WH, Dawood FS. JAMA network open, 2025 Apr 1; 8 (4): e252841 DOI:10.1001/jamanetworkopen.2025.2841
      PMID: 40168024
    • Journal Article
      Looking Forward: The Journal of Infectious Diseases in 2025
      Clancy C, Lauring A, Li J, Sears C. Journal of Infectious Diseases, 2025 Mar 15; 231 (3): 547 - 548. DOI:10.1093/infdis/jiaf020
      PMID: 39836138
    • Journal Article
      Respiratory Viral Infections From 2015 to 2022 in the HIVE Cohort of American Households: Incidence, Illness Characteristics, and Seasonality
      Monto AS, Foster-Tucker JE, Callear AP, Leis AM, Godonou ET, Smith M, Truscon R, Johnson E, Thomas LJ, Thompson MS, Fry AM, Flannery B, Malosh RE, Petrie JG, Lauring AS, Martin ET. Journal of Infectious Diseases, 2025 Mar 15; 231 (3): 795 - 804. DOI:10.1093/infdis/jiae423
      PMID: 39179953
    Featured News & Stories COVID19 in immunocompromised patients webinar vector magnifying glass looking at COVID
    Department News
    CME Offering: COVID-19 in Immunocompromised Patients: Unique Clinical Considerations and Management Strategies for the Busy Clinician
    Join us for a free CME webinar, COVID-19 in immunocompromised Patients: Unique Clinical Considerations and Management Strategies for the Busy Clinician, on Wednesday, May 7, 2025, from 12:00 - 1:00 pm ET.
    Health Lab
    This season’s flu and COVID shots helped prevent serious illness
    So far, this season's flu and COVID vaccines appear to have been effective at preventing serious illness, finds a study from U-M experts and others
         Adam Lauring, MD, PhD
    Department News
    Adam Lauring, M.D., Ph.D., is the new Chief of the Division of Infectious Diseases in the Department of Internal Medicine
    Effective April 1, 2025, Dr. Adam Lauring, M.D., Ph.D., will serve as Chief of the Division of Infectious Diseases in the Department of Internal Medicine Dr. Lauring is a Professor of Internal Medicine and Professor of Microbiology and Immunology in the Medical School and a Professor of Ecology and Evolutionary Biology in the College of Literature, Science, and the Arts at the University of Michigan. He brings a wealth of experience in infectious disease research, clinical care, and mentorship.
         Kirschner, Lauring and Martens elected into the AAM
    Department News
    Three M&I Faculty were elected into the American Academy of Microbiology
    U-M microbiology and immunology professors Denise Kirschner, Ph.D., Adam Lauring, M.D., Ph.D., and Eric Martins, Ph.D.  were recently elected as Fellows of the American Academy of Microbiology. These elections further demonstrate the excellence of the U-M Department of Microbiology and Immunology.
         pigs sick and chickens in background with blue background and green cells floating around
    Health Lab
    Why the bird flu’s jump to pigs is concerning
    A Michigan Medicine virologist speaks about the implications of H5N1 influenza, or bird flu, and whether a new pandemic could be on the horizon.
    News Release
    Building a COMPASS to navigate future pandemics
    An $18 million National Science Foundation grant will establish a new center to bring computer science, infectious disease, engineering, and the arts together to predict and prevent global pandemics